Anti-Substance P antibody [SP-DE4-21] (ab14184)

Publishing research using ab14184? Please let us know so that we can cite the reference in this datasheet.

ab14184 has been referenced in 7 publications.

  • Tratnjek L  et al. Upregulation and axonal transport of synaptotagmin-IV in the direct-pathway medium spiny neurons in hemi-parkinsonian rats induced by dopamine D1 receptor stimulation. Eur J Neurosci 43:885-98 (2016). PubMed: 26750488
  • Arosh JA  et al. Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis. Proc Natl Acad Sci U S A 112:9716-21 (2015). IHC-Fr ; Mouse . PubMed: 26199416
  • Colas D  et al. Orexin A and orexin receptor 1 axonal traffic in dorsal roots at the CNS/PNS interface. Front Neurosci 8:20 (2014). ICC/IF ; Rat . PubMed: 24574957
  • Maguma HT  et al. Specific localization of ß-Arrestin2 in myenteric plexus of mouse gastrointestinal tract. PLoS One 9:e103894 (2014). IHC (PFA fixed) ; Mouse . PubMed: 25083714
  • Murphy SR  et al. Ozone-induced airway epithelial cell death, the neurokinin-1 receptor pathway, and the postnatal developing lung. Am J Physiol Lung Cell Mol Physiol 307:L471-81 (2014). PubMed: 25063800
  • Mijouin L  et al. Effects of a skin neuropeptide (substance p) on cutaneous microflora. PLoS One 8:e78773 (2013). PubMed: 24250813
  • Meng J  et al. Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J Cell Sci 120:2864-74 (2007). ICC/IF ; Rat . PubMed: 17666428

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"